| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Molecular Biology [L. Y., D. R. C.], Preventive Medicine [W. D. D.], and Pathology [F. F. P.], Vanderbilt University, Nashville, Tennessee 37232
The presence of estrogen receptor (ER) is a well-known predictor of clinical outcome in human breast cancer. We examined the ER gene in 26 primary breast cancers (14 ER-positive, 12 ER-negative) to determine if alterations of the gene are associated with the ER-negative status. In tumor biopsies and peripheral blood DNA obtained from the same patients we analyzed the ER exon structure using polymerase chain reaction amplification, restriction endonuclease digestion, and agarose gel electrophoresis. All blood and tumor samples, regardless of ER status, showed a complete set of eight exons of normal sizes, ruling out deletions or rearrangements of the ER gene in excess of ±20 nucleotides. Previous reports indicate that the two-allele ER PvuII polymorphism could be associated with ER expression in breast cancer (Hill et al., Cancer Res., 49: 145148, 1989) as well as with patient age at time of tumor diagnosis (Parl et al., Breast Cancer Res. Treat., 14: 5764, 1989). We localized the PvuII polymorphism in intron 1, 0.4 kilobase upstream of exon 2. Sequence analysis showed the polymorphism to result from a point mutation (T
C) at the fifth position of the restriction site (CATCTG). We determined the PvuII restriction fragment-length polymorphism genotype in 257 primary breast cancers and 140 peripheral blood DNA samples obtained from women without breast cancer. The results indicate that the PvuII polymorphism is not associated with ER content or patient age at tumor diagnosis.
1 This work was supported by American Cancer Society Grant PDT-420 (F. F. P. and D. R. C.).
2 To whom requests for reprints should be addressed, at Department of Pathology, Vanderbilt University, Nashville, TN 37232.
Received 6/13/91. Accepted 10/22/91.
This article has been cited by other articles:
![]() |
A. Morandi Alessio, L. H. Siqueira, E. C. Couto de Carvalho, R. Barini, A. de Padua Mansur, N. Fenalti Hoehr, and J. M. Annichino-Bizzacchi Estrogen Receptor Alpha and Beta Gene Polymorphisms Are Not Risk Factors for Recurrent Miscarriage in a Brazilian Population Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 180 - 185. [Abstract] [PDF] |
||||
![]() |
R.M. Corbo, L. Ulizzi, L. Piombo, C. Martinez-Labarga, G.F. De Stefano, and R. Scacchi Estrogen receptor alpha polymorphisms and fertility in populations with different reproductive patterns Mol. Hum. Reprod., August 1, 2007; 13(8): 537 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Alevizaki, K Saltiki, A Cimponeriu, I Kanakakis, N Xita, C C Alevizaki, I Georgiou, and H-L Sarika Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor {alpha} polymorphic variants Eur. J. Endocrinol., April 1, 2007; 156(4): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Kjaergaard, C. Ellervik, A. Tybjaerg-Hansen, C. K. Axelsson, M.-L. M. Gronholdt, P. Grande, G. B. Jensen, and B. G. Nordestgaard Estrogen Receptor {alpha} Polymorphism and Risk of Cardiovascular Disease, Cancer, and Hip Fracture: Cross-Sectional, Cohort, and Case-Control Studies and a Meta-Analysis Circulation, February 20, 2007; 115(7): 861 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen, D.-K. Li, J. Wu, Z. Zhang, and E. Gao Joint Effects of the CYP1A1 MspI, ER{alpha} PvuII, and ER{alpha} XbaI Polymorphisms on the Risk of Breast Cancer: Results from a Population-Based Case-Control Study in Shanghai, China. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 342 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Stavrou, C. Zois, A. Chatzikyriakidou, I. Georgiou, and A. Tsatsoulis Combined estrogen receptor {alpha} and estrogen receptor beta genotypes influence the age of menarche Hum. Reprod., February 1, 2006; 21(2): 554 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
S P Renner, R Strick, P Oppelt, P A Fasching, S Engel, R Baumann, M W Beckmann, and P L Strissel Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis Reproduction, January 1, 2006; 131(1): 153 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L Hall, K. Vafeiadou, J. Hallund, S. Bugel, C. Koebnick, M. Reimann, M. Ferrari, F. Branca, D. Talbot, T. Dadd, et al. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1260 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J.B. van Duijnhoven, I. D. Bezemer, P. H.M. Peeters, M. Roest, A. G. Uitterlinden, D. E. Grobbee, and C. H. van Gils Polymorphisms in the Estrogen Receptor {alpha} Gene and Mammographic Density Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2655 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Kok, N. C. Onland-Moret, K. M. van Asselt, C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee, and P. H.M. Peeters No association of estrogen receptor {alpha} and cytochrome P450c17{alpha} polymorphisms with age at menopause in a Dutch cohort Hum. Reprod., February 1, 2005; 20(2): 536 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Boyapati, X. O. Shu, Z. X. Ruan, Q. Cai, J. R. Smith, W. Wen, Y.-T. Gao, and W. Zheng Polymorphisms in ER-{alpha} Gene Interact with Estrogen Receptor Status in Breast Cancer Survival Clin. Cancer Res., February 1, 2005; 11(3): 1093 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsushita, T. Kurabayashi, M. Tomita, and K. Tanaka Effects of vitamin D and estrogen receptor gene polymorphisms on the changes in lumbar bone mineral density with multiple pregnancies in Japanese women Hum. Reprod., January 1, 2004; 19(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ferrero, F. Ribichini, G. Matullo, S. Guarrera, S. Carturan, A. Vado, C. Vassanelli, A. Piazza, E. Uslenghi, and W. Wijns Estrogen Receptor-{alpha} Polymorphisms and Angiographic Outcome After Coronary Artery Stenting Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2223 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Shearman, L. A. Cupples, S. Demissie, I. Peter, C. H. Schmid, R. H. Karas, M. E. Mendelsohn, D. E. Housman, and D. Levy Association Between Estrogen Receptor {alpha} Gene Variation and Cardiovascular Disease JAMA, November 5, 2003; 290(17): 2263 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cai, X.-O. Shu, F. Jin, Q. Dai, W. Wen, J.-R. Cheng, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in the Estrogen Receptor {alpha} Gene and Risk of Breast Cancer: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 853 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Iwamoto, T. Fujino, T. Douchi, and Y. Nagata Association of Estrogen Receptor {alpha} and {beta}3-Adrenergic Receptor Polymorphisms With Endometrial Cancer Obstet. Gynecol., September 1, 2003; 102(3): 506 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B.J. van Meurs, S. C.E. Schuit, A. E.A.M. Weel, M. van der Klift, A. P. Bergink, P. P. Arp, E. M. Colin, Y. Fang, A. Hofman, C. M. van Duijn, et al. Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk Hum. Mol. Genet., July 15, 2003; 12(14): 1745 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, T. Higashikata, A. Inazu, A. Nohara, W. Yu, M. Shimizu, and H. Mabuchi Association of Estrogen Receptor-{alpha} Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 817 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Herrington, T. D. Howard, G. A. Hawkins, D. M. Reboussin, J. Xu, S. L. Zheng, K. B. Brosnihan, D. A. Meyers, and E. R. Bleecker Estrogen-Receptor Polymorphisms and Effects of Estrogen Replacement on High-Density Lipoprotein Cholesterol in Women with Coronary Disease N. Engl. J. Med., March 28, 2002; 346(13): 967 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Herrington and K. P. Klein Genome and Hormones: Gender Differences in Physiology: Invited Review: Pharmacogenetics of estrogen replacement therapy J Appl Physiol, December 1, 2001; 91(6): 2776 - 2784. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M. Mattila, M. Luomala, T. Lehtimaki, P. Laippala, T. Koivula, and I. Elovaara Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women Neurology, May 8, 2001; 56(9): 1246 - 1247. [Full Text] [PDF] |
||||
![]() |
C. Sundarrajan, W. X. Liao, A. C. Roy, and S. C. Ng Association between Estrogen Receptor-{beta} Gene Polymorphisms and Ovulatory Dysfunctions in Patients with Menstrual Disorders J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 135 - 139. [Abstract] [Full Text] |
||||
![]() |
J. Kitawaki, H. Obayashi, H. Ishihara, H. Koshiba, I. Kusuki, N. Kado, K. Tsukamoto, G. Hasegawa, N. Nakamura, and H. Honjo Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata Hum. Reprod., January 1, 2001; 16(1): 51 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-W. Deng, J. Li, J.-L. Li, R. Dowd, K. M. Davies, M. Johnson, G. Gong, H. Deng, and R. R. Recker Association of Estrogen Receptor-{alpha} Genotypes with Body Mass Index in Normal Healthy Postmenopausal Caucasian Women J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2748 - 2751. [Abstract] [Full Text] |
||||
![]() |
E. Weiderpass, I. Persson, H. Melhus, S. Wedren, A. Kindmark, and J. A. Baron Estrogen receptor {alpha} gene polymorphisms and endometrial cancer risk Carcinogenesis, April 1, 2000; 21(4): 623 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yang, J. A. Martignetti, S. M. Massa, and F. M. Longo Leukocyte common-antigen-related tyrosine phosphatase receptor: altered expression of mRNA and protein in the New England Deaconess Hospital rat line exhibiting spontaneous pheochromocytoma Carcinogenesis, February 1, 2000; 21(2): 125 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. A. M. Weel, A. G. Uitterlinden, I. C. D. Westendorp, H. Burger, S. C. E. Schuit, A. Hofman, T. J. M. Helmerhorst, J. P. T. M. van Leeuwen, and H. A. P. Pols Estrogen Receptor Polymorphism Predicts the Onset of Natural and Surgical Menopause J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3146 - 3150. [Abstract] [Full Text] |
||||
![]() |
C. Sundarrajan, W.-X. Liao, A.C. Roy, and S.C. Ng Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF Mol. Hum. Reprod., September 1, 1999; 5(9): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ushiyama, K. Mori, K. Inoue, J. Huang, J. Nishioka, and S. Hukuda Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis Ann Rheum Dis, January 1, 1999; 58(1): 7 - 10. [Abstract] [Full Text] |
||||
![]() |
C. Tao, T. Yu, S. Garnett, J. Briody, J. Knight, H. Woodhead, C. T Cowell;, and Z. MUGHAL Vitamin D receptor alleles predict growth and bone density in girls • Commentary Arch. Dis. Child., December 1, 1998; 79(6): 488 - 494. [Abstract] [Full Text] |
||||
![]() |
F. Suarez, C. Rossignol, and M. Garabédian Interactive Effect of Estradiol and Vitamin D Receptor Gene Polymorphisms as a Possible Determinant of Growth in Male and Female Infants J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3563 - 3568. [Abstract] [Full Text] |
||||
![]() |
Y. Matsubara, M. Murata, K. Kawano, T. Zama, N. Aoki, H. Yoshino, G. Watanabe, K. Ishikawa, and Y. Ikeda Genotype Distribution of Estrogen Receptor Polymorphisms in Men and Postmenopausal Women From Healthy and Coronary Populations and Its Relation to Serum Lipid Levels Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3006 - 3012. [Abstract] [Full Text] |
||||
![]() |
K. O. Han, I. G. Moon, Y. S. Kang, H. Y. Chung, H. K. Min, and I. K. Han Nonassociation of Estrogen Receptor Genotypes with Bone Mineral Density and Estrogen Responsiveness to Hormone Replacement Therapy in Korean Postmenopausal Women J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 991 - 995. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |